Skip to main content

Table 4 Overall deaths/breast cancer deaths, crude, and adjusted

From: Better survival after breast-conserving therapy compared to mastectomy when axillary node status is positive in early-stage breast cancer: a registry-based follow-up study of 6387 Norwegian women participating in screening, primarily operated between 1998 and 2009

  Crude Adjusted
Overall death (95% CI) Breast cancer death (95% CI) Overall death (95% CI) Breast cancer death (95% CI)
MTX
 T1N0M0 1.67 (1.27–2.21) 1.65 (1.04–2.62) 1.47 (1.11–1.96) 1.32 (0.83–2.12)
 T2N0M0 1.42 (0.86–2.32) 1.20 (0.66–2.20) 1.46 (0.86–2.42) 1.26 (0.68–2.33)
 T1N1M0 2.48 (1.45–4.24) 3.61 (1.69–7.72) 2.08 (1.19–3.64) 2.91 (1.30–6.48)
 T2N1M0 1.09 (0.63–1.90) 1.39 (0.71–2.72) 1.19 (0.66–2.15) 1.40 (0.69–2.86)
  1. The adjustments are done by screening detection category, years of diagnosis, screening age, nodal status, histology, grade, and hormone status (same as Table 3). BCT is base 1.0